Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Herde Insider Profile
4 Followers
Kevin Herde, Executive VP and CFO at Sorrento Therapeutics, holds 336.60K shares in Maravai Lifesciences Holdings (Ticker: MRVI), holds 4.00K shares in Sorrento Therapeutics (Ticker: SRNE).
Kevin Herde has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Herde holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 03, 2017 - Feb 03, 2018
Return:+50.00%
The most profitable trade made by Kevin Herde
Kevin Herde's Trading History
Sorrento Therapeutics
Feb 03, 2017
Executive VP and CFO
Informative Buy
15.45K
$40.00
Maravai Lifesciences Holdings
Nov 12, 2024
CFO
Uninformative Buy
10.86K
$1.62M
List of latest transactions for each holding click on a transaction to see Kevin Herde's performance on stock
You May Also Like
Kevin Herde insider profile FAQ
What is the percentage of profitable transactions made by Kevin Herde?
The percentage of profitable transactions made by Kevin Herde is ―.
What is the average return per transaction made by Kevin Herde?
The average return per transaction made by Kevin Herde is ―.
What stocks does Kevin Herde hold?
Kevin Herde holds: SRNE, MRVI stocks.
What was Kevin Herde’s latest transaction?
Kevin Herde latest transaction was an Uninformative Buy of $10.86K.
What was Kevin Herde's most profitable transaction?
Kevin Herde’s most profitable transaction was an Informative Buy of SRNE stock on February 3, 2017. The return on the trade was 50.00%.
What is Kevin Herde's role in Sorrento Therapeutics?
Kevin Herde's role in Sorrento Therapeutics is Executive VP and CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.